Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma
Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma
复制标题
异柠檬酸脱氢酶 1 突变增强神经胶质瘤中 24(S)-羟基胆固醇的产生并改变胆固醇稳态
DOI:
10.1038/s41388-020-01439-0
复制
发表时间:
2020-08
期刊:
影响因子:
8
通讯作者:
Ye Jing
中科院分区:
文献类型:
--
作者:
Yang Risheng;Zhao Yuanlin;Gu Yu;Yang Ying;Gao Xing;Yuan Yuan;Xiao Liming;Zhang Jin;Sun Chao;Yang Han;Qin Junhui;Li Jing;Zhang Feng;Zhang Lijun;Ye Jing
Isocitrate dehydrogenase (IDH) mutation is the most important initiating event in gliomagenesis, and the increasing evidence shows that IDH mutation is associated with the metabolic reprogramming in the tumor. Dysregulated cholesterol metabolism is a hallmark of tumor cells, but the cholesterol homeostasis in IDH-mutated glioma is still unknown. In this study, we found that astrocyte-specific mutant IDH1(R132H) knockin reduced the cholesterol contents and damaged the structure of myelin in mouse brains. In U87 and U251 cells, the expression of mutant IDH1 consistently reduced the cholesterol levels. Furthermore, we found that IDH1 mutation enhanced the production of 24(S)-hydroxycholesterol (24-OHC), which is not only the metabolite of cholesterol elimination, but also functions as an endogenous ligand for the liver X receptors (LXRs). In IDH1-mutant glioma cells, the elevated 24-OHC activated LXRs, which consequently accelerated the low-density lipoprotein receptor (LDLR) degradation by upregulating the inducible degrader of the LDLR (IDOL). The reduced LDLR expressions in IDH1-mutant glioma cells abated the uptakes of low-density lipoprotein (LDL) to decrease the cholesterol influx. In addition, the activated LXRs also promoted the cholesterol efflux by elevating the ATP-binding cassette transporter A1 (ABCA1), ABCG1, and apolipoprotein E (ApoE) in both IDH1-mutant astrocytes and glioma cells. As a feedback, the reduced cholesterol levels stimulated the cholesterol biosynthesis, which made IDH1-mutated glioma cells more sensitive to atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase. The altered cholesterol homeostasis regulated by mutant IDH provides a pivotal therapeutical strategy for the IDH-mutated gliomas.
登录
查看更多内容
DOI:
10.1073/pnas.96.13.7238
发表时间:
1999-06-22
影响因子:
11.1
作者:
Lund, EG;Guileyardo, JM;Russell, DW
通讯作者:
Russell, DW
DOI:
10.1126/science.1168974
发表时间:
2009-07-03
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Zelcer N;Hong C;Boyadjian R;Tontonoz P
通讯作者:
Tontonoz P
影响因子:
4.5
作者:
Zhang Jin;Gao Xing;Yuan Yuan;Sun Chao;Zhao Yuanlin;Xiao Liming;Yang Ying;Gu Yu;Yang Risheng;Hu Peizhen;Zhang Lijun;Wang Chao;Ye Jing
通讯作者:
Ye Jing
影响因子:
4.7
作者:
Fujiyoshi, Masachika;Ohtsuki, Sumio;Terasaki, Tetsuya
通讯作者:
Terasaki, Tetsuya
影响因子:
64.8
作者:
Lu, Chao;Ward, Patrick S.;Kapoor, Gurpreet S.;Rohle, Dan;Turcan, Sevin;Abdel-Wahab, Omar;Edwards, Christopher R.;Khanin, Raya;Figueroa, Maria E.;Melnick, Ari;Wellen, Kathryn E.;O'Rourke, Donald M.;Berger, Shelley L.;Chan, Timothy A.;Levine, Ross L.;Mellinghoff, Ingo K.;Thompson, Craig B.
通讯作者:
Thompson, Craig B.